SL Science Holding Limited Ordinary Shares (SLBT)
Stock · NASDAQ · Health Care
$1.5as of 10/16/2026
Price chart
Active signals
SLBT Signal Track Record
How signals performed across all stocks →What SLBT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 7 | -7.6% | 43% | September 2, 2026 |
| Bollinger Band Breakdown | 5 | -13.5% | 40% | September 10, 2026 |
| Volume Spike | 4 | -28.9% | 25% | September 25, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -47.7% | 0% | June 5, 2026 |
| Any 20-session window (baseline) | -7.2% | 39% |
Computed by MarketWall from daily closing prices since November 19, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SLBT
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 14
- Website
- www.slbtgroup.com
Fundamentals
- 1-day range
- $1.5$1.55
- Market cap
- $1.53B
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.01
- Dividend yield
- —
- Beta
- 6.78
- Avg. volume
- 80.8K
SL Science Holding Limited Ordinary Shares Competitors
Chosen by industry and closest market cap.
- SLBTSL Science Holding Limited Ordinary Shares$1.53▼ 1.29%Market cap $1.53BP/E —$1.42$14.5
- MAZEMaze Therapeutics Inc. Common Stock$27.53▲ 0.18%Market cap $1.58BP/E —$21.95$53.65
- VIRVir Biotechnology Inc. Common Stock$9.96▼ 4.87%Market cap $1.48BP/E —$4.82$12
- IMCRImmunocore Holdings plc American Depositary Shares$29.4▼ 0.27%Market cap $1.66BP/E —$27.5$40.71
- RXRXRecursion Pharmaceuticals Inc. Class A Common Stock$3.46▼ 16.71%Market cap $1.69BP/E —$2.77$7.18
- GLUEMonte Rosa Therapeutics Inc. Common Stock$9.74▼ 3.75%Market cap $1.33BP/E —$8.94$25.77
- VORVor Biopharma Inc. Common Stock$18.03▼ 6.77%Market cap $1.28BP/E 1.82$6.5$33.42
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SLBT SL Science Holding Limited Ordinary Shares | $1.53B | — | $1.53 | ▼ 1.29% | $1.42$14.5 |
| MAZE Maze Therapeutics Inc. Common Stock | $1.58B | — | $27.53 | ▲ 0.18% | $21.95$53.65 |
| VIR Vir Biotechnology Inc. Common Stock | $1.48B | — | $9.96 | ▼ 4.87% | $4.82$12 |
| IMCR Immunocore Holdings plc American Depositary Shares | $1.66B | — | $29.4 | ▼ 0.27% | $27.5$40.71 |
| RXRX Recursion Pharmaceuticals Inc. Class A Common Stock | $1.69B | — | $3.46 | ▼ 16.71% | $2.77$7.18 |
| GLUE Monte Rosa Therapeutics Inc. Common Stock | $1.33B | — | $9.74 | ▼ 3.75% | $8.94$25.77 |
| VOR Vor Biopharma Inc. Common Stock | $1.28B | 1.82 | $18.03 | ▼ 6.77% | $6.5$33.42 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/28/2026
- Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On MondayBenzinga · 9/28/2026
- SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant GlioblastomaYahoo · 9/24/2026
- SL Science: A $1.15 Billion Valuation Built On Preclinical PromisesSeekingAlpha · 9/16/2026
Insider Activity
Insider Actions →- Wang Ching-Dong · September 29, 2026 · Buy4.55M @ $2,272,653
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
SLBT Rings Nasdaq Bell After First Quarter as Public Company
SL Science Holding Limited rang the Nasdaq opening bell on Thursday, marking an event tied to its first quarter operating as a publicly traded company. The ceremony highlights the company's recent transition to public markets, though specific operational or financial milestones from the quarter were not detailed in the announcement. SLBT also appeared in broader pre-market movers lists, reflecting heightened trading activity around the bell-ringing event. The stock has traded in a wide 52-week range of $2.51 to $14.50, suggesting notable volatility since its listing.
SLBT Rings Nasdaq Bell After First Quarter as Public Company. SL Science Holding Limited rang the Nasdaq opening bell on Thursday, marking an event tied to its first quarter operating as a publicly traded company. The ceremony highlights the company's recent transition to public markets, though specific operational or financial milestones from the quarter were not detailed in the announcement. SLBT also appeared in broader pre-market movers lists, reflecting heightened trading activity around the bell-ringing event. The stock has traded in a wide 52-week range of $2.51 to $14.50, suggesting notable volatility since its listing.